Conclusions
Atrial and dual defibrillators held great promise when they were introduced in the 1990s.
The devices are effective and safe in selected patients. Tolerability and acceptance by patients is good in the short term but only moderate in the longer term. The complication rate is relatively low. However, advances in ablation techniques for the treatment of atrial fibrillation have limited and will continue to limit the use of implantable atrial defibrillators. In combination with ICDs they may find a continued role in a patient group that should be further defined.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Singh BN, Singh SN, Reda DJ et al (2005) Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 352:1861–1872
Lévy S, Lauribe P, Dolla E et al (1992) A randomised comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 86:1415–1420
Wellens H, Lau C-P, Lüderitz B et al (1998) Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 98:1651–1656
Daoud EG, Timmermans C, Fellows C et al (2000) Initial clinical experience with ambulatory use of an implantable atrial defibrillator for conversion of atrial fibrillation. Metrix Investigators. Circulation102:1407–1413
Gold MR, Sulke N, Schwartzman DS et al (2001) Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. J Cardiovasc Electrophysiol 12:1247–1253
Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237
Kadish A, Dyer A, Daubert JP et al (2004) Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350:2151–2158
Gronefeld GC, Mauss O, Li YG et al (2000) Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol 11:1208–1214
Friedman PA, Dijkman B, Warman EN et al for the Worldwide Jewel AF Investigators (2001) Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 104:1023–1028
Spurrell P, Mitchell A, Kamalvand K et al (2004) Does sinus rhythm beget sinus rhythm? Long-term follow-up of the patient activated atrial defibrillator. Pacing Clin Electrophysiol 27:175–181
Timmermans C, Levy S, Ayers GM et al (2000) Spontaneous episodes of atrial fibrillation after implantation of the Metrix Atrioverter: observations on treated and nontreated episodes. Metrix Investigators. J Am Coll Cardiol 35:1428–1433
Ricci R, Pignalberi C, Disertori M et al (2002) Efficacy of a dual chamber defibrillator with atrial antitachycardia functions in treating spontaneous atrial tachyarrhythmias in patients with life-threatening ventricular tachyarrhythmias. Eur Heart J 23:1471–1479
Ricci R, Pignalberi C, Santini M (2003) Efficacy of atrial antitachycardia functions for treating atrial fibrillation: observations in patients with a dual-chamber defibrillator. Card Electrophysiol Rev 7:348–351
Schwartzman D, Musley SK, Swerdlow C et al (2002) Early recurrence of atrial fibrillation after ambulatory shock conversion. J Am Coll Cardiol 40:93–99
Geller JC, Reek S, Timmermans C et al (2003) Treatment of atrial fibrillation with an implantable atrial defibrillator — long term results. Eur Heart J 24:2083–2089
Newman DM, Dorian P, Paquette M et al (2003) Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of life. Am Heart J 145:841–846
Ricci R, Quesada A, Pignalberi C et al (2004) Dual defibrillator improves quality of life and decreases hospitalizations in patients with drug refractory atrial fibrillation. J Interv Card Electrophysiol 10:85–92
Burns JL, Sears SF, Sotile R et al (2004) Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study. J Cardiovasc Electrophysiol 15:286–291
Boodhoo L, Mitchell A, Ujhelyi M et al (2004) Improving the acceptability of the atrial defibrillator: patient-activated cardioversion versus automatic night cardioversion with and without sedation (ADSAS 2). Pacing Clin Electrophysiol 27:910–917
Mitchell AR, Spurrell PA, Gerritse BE et al (2004) Improving the acceptability of the atrial defibrillator for the treatment of persistent atrial fibrillation: the atrial defibrillator sedation assessment study (ADSAS). Int J Cardiol 96:141–145
Haïssaguerre M, Jaïs P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666
Hocini M, Sanders P, Jaïs P et al (2004) Techniques for curative treatment of atrial fibrillation. J Cardiovasc Electrophysiol 15:1467–1471
Hsu LF, Jaïs P, Sanders P et al (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this chapter
Cite this chapter
Mekel, J.M., Thornton, A.S., Theuns, D.A.M.J., Jordaens, L.J. (2006). Long-Term Use of the Atrial and Dual Defibrillator: What Have We Learned?. In: Raviele, A. (eds) Cardiac Arrhythmias 2005. Springer, Milano. https://doi.org/10.1007/88-470-0371-7_34
Download citation
DOI: https://doi.org/10.1007/88-470-0371-7_34
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0370-5
Online ISBN: 978-88-470-0371-2
eBook Packages: MedicineMedicine (R0)